0001104659-20-034208.txt : 20200316
0001104659-20-034208.hdr.sgml : 20200316
20200316175100
ACCESSION NUMBER: 0001104659-20-034208
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200313
FILED AS OF DATE: 20200316
DATE AS OF CHANGE: 20200316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Young Jonathan
CENTRAL INDEX KEY: 0001779805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 20718496
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 3RD FL
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
a4.xml
4
X0306
4
2020-03-13
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001779805
Young Jonathan
C/O AKERO THERAPEUTICS,
INC., 170 HARBOR WAY, 3RD FLOOR
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Operating Officer
Common Stock
2020-03-13
4
M
0
5035
0.615
A
177518
D
Common Stock
2020-03-13
4
M
0
6082
0.615
A
183600
D
Common Stock
20000
I
By EA Irrevocable Trust
Common Stock
20000
I
By CM Irrevocable Trust
Common Stock
20000
I
By JL Irrevocable Trust
Stock Option (Right to Buy)
0.615
2020-03-13
4
M
0
5035
0
D
2028-07-29
Common Stock
5035
42796
D
Stock Option (Right to Buy)
0.615
2020-03-13
4
M
0
6082
0
D
2028-10-17
Common Stock
6082
94268
D
Due to a clerical error in the preparation of the reporting person's Form 3, the reporting person's beneficial ownership was overstated by 60,000 on the Form 3 filed on June 19, 2019 and the Form 4s filed on December 31, 2019 and January 10, 2019 as the 60,000 shares that are indicated as being owned by the EA Irrevocable Trust, CM Irrevocable Trust and JL Irrevocable Trust were not removed from the reporting person's direct ownership total reported in column 5. That error has been corrected in this Form 4.
These shares are held in irrevocable trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
25% of this option vested on August 1, 2018 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.
Shares vested and became exercisable in equal monthly installments for a period of 48 months following October 1, 2018.
/s/ Jonathan Young
2020-03-16